NEW YORK, Oct. 6, 2021 /PRNewswire/ -- WindRose Health
Investors, LLC ("WindRose"), the New
York-based healthcare private equity firm, announced today
that it has completed the sale of Vital Decisions, LLC ("Vital
Decisions" or the "Company") to Evolent Health, Inc. ("Evolent
Health"). Vital Decisions will report into Evolent's specialty
management offering, New Century Health, and will be consolidated
into Evolent's Clinical Solutions segment.
Founded in 2006, and headquartered in Edison, New Jersey, Vital Decisions is a
leading provider of technology-enabled advance care-planning
services, ensuring that the care of individuals with serious
illness aligns with their values and changing preferences
throughout every step of their health journey. Enabled by
behavioral science methodologies, proprietary analytics, and
clinical experts, Vital Decisions provides collaborative decision
making and advance care-planning support for all members of a
health plan's population through a suite of telehealth and digital
solutions. WindRose completed its majority investment in Vital
Decisions in December 2012.
"We are proud to have partnered with the Vital Decisions
management team as they significantly expanded their business and
capabilities," said Oliver Moses,
Managing Partner of WindRose. "Vital Decisions' model has proven
that through empowering individuals to take an active role in their
care-plan, you can improve the quality of life for those with an
advanced illness and reduce costs for the healthcare marketplace.
We are pleased to have found an excellent partner for Vital
Decisions in Evolent Health, which shares our commitment to
aligning treatment goals among individuals, their family members,
and healthcare providers."
"WindRose has been a valued partner to Vital Decisions as we
developed our service offerings and enhanced our proprietary
analytics and digital solutions, and we are thankful to have had
them by our side," said Mitchell
Daitz, Co-Founder and Executive Chairman of the Company.
"Vital Decisions was formed as a patient-focused platform to
enhance alignment among patients, families, and providers regarding
the care that is delivered during an advanced illness. Through our
economic studies and peer-reviewed research, we found that up to
35% of costs in the last six months of life are for services that
are unwarranted or unwanted. New Century's focus on driving
outcomes through peer-led provider collaboration will enhance the
effectiveness of Vital Decisions' services, and we look forward to
the partnership."
McDermott Will & Emery LLP
acted as legal advisor for Vital Decisions. Bass, Berry & Sims
PLC is acting as legal counsel to Evolent.
About Vital Decisions
Headquartered in Edison, NJ,
Vital Decisions ensures that the care of individuals with serious
illness or in a medical crisis aligns with their values and wishes.
Enabled by behavioral science methodologies, proprietary analytics,
and clinical experts, Vital Decisions provides collaborative
decision making and advance care-planning support for all members
of a health plan's population through a suite of telehealth and
digital solutions. The services help individuals and their families
think through, communicate, and document their preferences to
ensure their care is aligned with their wishes - now and in the
future as their medical situation changes. Vital Decisions'
solutions include personalized discussions with highly trained
clinical specialists, education and referrals to palliative care,
hospice and other available services, and online tools to document
and share advance care preferences. These services result in
improved quality and high satisfaction among individuals, their
families, and their doctors.
For more information visit www.vitaldecisions.net.
About WindRose
WindRose Health Investors, LLC ("WindRose") makes equity
investments in companies that operate within the services sectors
of the healthcare industry. The firm focuses on companies with
profitable business models and a demonstrated ability to deliver
cost-effective solutions. WindRose manages over $1.2 billion in investments and is currently
investing out of its fifth fund. WindRose is based in New York City and invests in companies
throughout the United States.
For more information, please email WindRose at
info@windrose.com.
About Evolent Health
Evolent Health (NYSE: EVH) delivers proven clinical and
administrative solutions that improve whole-person health while
making health care simpler and more affordable. Our solutions
encompass total cost of care management, specialty care management,
and administrative simplification. Evolent serves a national base
of leading payers and providers, is the first company to receive
the National Committee for Quality Assurance's Population Health
Program Accreditation, and is consistently recognized as a top
place to work in health care nationally.
For more information, visit www.evolenthealth.com.
Media Contact:
Caroline Luz
Lambert & Co.
203-656-2829
cluz@lambert.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/windrose-health-investors-completes-the-sale-of-vital-decisions-to-evolent-health-301393714.html
SOURCE WindRose Health Investors